Study of Ravulizumab in Pediatric Participants With HSCT-TMA

计划入组 41 人 · 首次发布于 2020 年 9 月 22 日

Study in Adult and Pediatric Patients With HSCT-TMA

首次发布于 2021 年 7 月 21 日

Single Patient Expanded Access Treatment Plan For The Investigational Product Narsoplimab

首次发布于 2020 年 1 月 30 日

TMA-015

TMA-230

TMA-11

CENEXI HSC

France

TMC Healthcare

United States

EDAP TMS

France

Ultomiris Phase III Trial Misses Primary Endpoint in Adults with HSCT-TMA, But Paediatric Data Show Clinically Meaningful Survival Benefit

EMA Rejects Omeros' Narsoplimab for Stem Cell Transplant Complication, Citing Insufficient Efficacy Data

EU Approves Apellis and Sobi's Aspaveli for PNH with Restricted Label